JP2019506134A5 - - Google Patents

Download PDF

Info

Publication number
JP2019506134A5
JP2019506134A5 JP2018519751A JP2018519751A JP2019506134A5 JP 2019506134 A5 JP2019506134 A5 JP 2019506134A5 JP 2018519751 A JP2018519751 A JP 2018519751A JP 2018519751 A JP2018519751 A JP 2018519751A JP 2019506134 A5 JP2019506134 A5 JP 2019506134A5
Authority
JP
Japan
Prior art keywords
medium
ali
william
spheroids
complete
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018519751A
Other languages
English (en)
Japanese (ja)
Other versions
JP6810742B2 (ja
JP2019506134A (ja
Filing date
Publication date
Priority claimed from EP16185725.5A external-priority patent/EP3287521B1/en
Application filed filed Critical
Publication of JP2019506134A publication Critical patent/JP2019506134A/ja
Publication of JP2019506134A5 publication Critical patent/JP2019506134A5/ja
Application granted granted Critical
Publication of JP6810742B2 publication Critical patent/JP6810742B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018519751A 2016-08-25 2017-08-17 細胞培養 Active JP6810742B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16185725.5A EP3287521B1 (en) 2016-08-25 2016-08-25 Cell culture
EP16185725.5 2016-08-25
PCT/EP2017/070881 WO2018036910A1 (en) 2016-08-25 2017-08-17 Cell culture

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020205752A Division JP7097942B2 (ja) 2016-08-25 2020-12-11 細胞培養

Publications (3)

Publication Number Publication Date
JP2019506134A JP2019506134A (ja) 2019-03-07
JP2019506134A5 true JP2019506134A5 (enExample) 2020-07-16
JP6810742B2 JP6810742B2 (ja) 2021-01-06

Family

ID=56842661

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018519751A Active JP6810742B2 (ja) 2016-08-25 2017-08-17 細胞培養
JP2020205752A Active JP7097942B2 (ja) 2016-08-25 2020-12-11 細胞培養

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020205752A Active JP7097942B2 (ja) 2016-08-25 2020-12-11 細胞培養

Country Status (8)

Country Link
US (2) US11041145B2 (enExample)
EP (2) EP3940059A1 (enExample)
JP (2) JP6810742B2 (enExample)
KR (1) KR20180049000A (enExample)
CN (1) CN108138135A (enExample)
PL (1) PL3287521T3 (enExample)
RU (1) RU2018111219A (enExample)
WO (1) WO2018036910A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3794107A1 (en) * 2018-05-16 2021-03-24 Institut National de la Santé et de la Recherche Médicale (INSERM) Method of culturing proliferative hepatocytes
EP3927417A4 (en) * 2019-02-19 2022-11-16 Iontox LLC METHODS FOR PREDICTING REPEATED DOSE TOXICITY USING AN INTEGRATED ORGAN PLATFORM
CN113699202A (zh) * 2020-05-21 2021-11-26 华子昂 一种用混合细胞与人工细胞培养巢制备胶原蛋白的方法
EP4366873A4 (en) * 2021-07-08 2025-08-06 Ourotech Inc SYSTEMS AND METHODS FOR PREDICTING TREATMENT EFFECTIVENESS
CN120005810A (zh) * 2025-04-18 2025-05-16 立沃生物科技(深圳)有限公司 肝祖细胞、应用及3d动态培养扩增方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2313377B (en) 1996-05-20 1998-07-01 Sumitomo Chemical Co Kit for diagnosis of hepatitis C and alcoholic cirrhosis
GB9913979D0 (en) 1999-06-17 1999-08-18 Univ Wales Medicine Spheroid preparation
US7351584B2 (en) 2002-02-26 2008-04-01 In Vitro Technologies, Inc. Hepatocyte bioreactor system for long term culture of functional hepatocyte spheroids
WO2003080821A1 (en) 2002-03-25 2003-10-02 Japan Science And Technology Agency Method of proliferating human hepatocytes and method of obtaining human hepatocytes
US7753192B2 (en) 2005-12-23 2010-07-13 The Coca-Cola Company Apparatus and method for orienting spheroidal containers and packaging beverages in spheroidal containers
JP5217220B2 (ja) 2007-04-12 2013-06-19 株式会社日立製作所 細胞分離装置
SG183067A1 (en) * 2007-07-20 2012-08-30 Cellartis Ab A novel population of hepatocytes derived via definitive endoderm (de-hep) from human blastocysts derived stem cells
US20110262956A1 (en) 2008-10-07 2011-10-27 Guillermo Munoz Elias Co-culture compositions and methods
JP5337169B2 (ja) 2009-01-08 2013-11-06 株式会社日立製作所 動物肝細胞の培養方法
GB201104511D0 (en) * 2011-03-17 2011-05-04 Univ Cardiff Cell based screening assay
JP5812816B2 (ja) * 2011-11-15 2015-11-17 コバレントマテリアル株式会社 細胞培養担体及びその製造方法
DE102011121317A1 (de) 2011-12-16 2013-06-20 Universitätsklinikum Hamburg-Eppendorf Gerüstfreie Leberzellaggregate zur Verwendung bei der Transplantation
CN102559581B (zh) * 2012-01-20 2014-09-10 四川大学华西医院 一种无血清肝细胞培养基
US10677783B2 (en) 2012-09-27 2020-06-09 Corning Incorporated Method for evaluating effect of cytokine on metabolic activity of cytochrome P450, and drug screening method
US20140106356A1 (en) 2012-10-12 2014-04-17 National Taiwan University Kit for drug metabolism determination and toxicity prediction
US9442105B2 (en) * 2013-03-15 2016-09-13 Organovo, Inc. Engineered liver tissues, arrays thereof, and methods of making the same
WO2015163043A1 (ja) 2014-04-22 2015-10-29 株式会社日本触媒 フッ素含有ポリマーを表面に含む細胞培養用基材
JP6681664B2 (ja) * 2014-09-05 2020-04-15 株式会社日本触媒 含フッ素ポリイミドを含む酸素ガス透過性の細胞培養用基材、該基材を備えた細胞培養用容器、及び、該基材を用いた細胞培養方法

Similar Documents

Publication Publication Date Title
JP2019506134A5 (enExample)
Coles et al. Optimal truncation in matching markets
Green et al. Broker-hosted investor conferences
Biais et al. Equilibrium fast trading
Zheng et al. What drives spatial clusters of entrepreneurship in China? Evidence from economic census data
Rocheteau et al. Liquidity provision, interest rates, and unemployment
Tsai Unified particle swarm delivers high efficiency to particle swarm optimization
JP2015520726A5 (enExample)
AR128816A2 (es) Formas de dosificación farmacéutica de perlas de cisteamina
JP2012236016A5 (enExample)
JP2017047613A5 (enExample)
HRP20201177T1 (hr) Terapijsko cjepivo za liječenje dijabetesa tipa 1 kod djece, primjena staničnog sortera i metoda umnožavanja treg stanica za proizvodnju terapijskog cjepiva za liječenje dijabetesa tipa 1
CN113038946A8 (zh) 用生物素组合物治疗自闭症和自闭症谱系障碍
JP2015510935A5 (enExample)
MX2020005802A (es) Metodos, entidades de red, entidad de exposicion de red y medios legibles por computadora para la configuracion de entrega de datos.
JP2016525752A5 (enExample)
My Using the Baldrige Leadership Model to Overcome Evasive Organizational Challenges
JP2013129858A5 (enExample)
AU2012101761A4 (en) Hair, Beauty & Photography Studio
World Health Organization The Andorra Statement: health promotion and disease prevention throughout the life-course: second high-level meeting of the WHO small countries initiative, Soldeu, Andorra, 2–3 July 2015
RU2013120240A (ru) Способ конверсии сульфата кальция
RU2021109614A (ru) N-бензоилгидразоны камфоры, используемые в качестве ингибиторов репликации ортопоксвирусов
Stonebraker {NewSQL} vs.{NoSQL} for New {OLTP}
Shih-yu Spirit Mediums in Western Hunan: An Ethnographic Report
Jian-jun et al. Research on Evaluation of the Policy Effects of China’s Sports Industry